Physician

Aaron Michael Bohrer, D.O.

According to 2025 Medicare claims, Aaron Bohrer, D.O. (NPI: 1548472079) practices internal medicine in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is MCLAREN GREATER LANSING (NPI: 1265579734; TIN: 381434090) and primary practice location at 48910-8556. Bohrer is affiliated with the POM ACO (ACO ID: A1297) and McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Bohrer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 105 traditional Medicare patients, billed 207 HCPCS/CPT codes, and received $12,943 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 2,992 prescription claims across 292 beneficiaries totaling $388,980 in drug costs, led by Ozempic (Semaglutide). DME data shows 19 claims. Open Payments data shows 11 records totaling $845. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $205,627 to $12,943. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $408,881 to $388,980. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $18,984 to $4,624.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	905	2,973	$205,627
2016	925	2,623	$174,622
2017	1,031	2,926	$194,880
2018	851	2,442	$152,570
2019	1,050	3,058	$213,455
2020	676	1,733	$117,899
2021	526	1,235	$84,310
2022	296	760	$49,460
2023	108	199	$12,851
2024	105	207	$12,943

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	354	3,896	$408,881
2016	374	4,441	$549,733
2017	379	4,373	$512,099
2018	372	4,049	$490,479
2019	310	1,436	$166,158
2020	86	172	$11,471
2021	66	140	$8,647
2022	70	160	$15,731
2023	137	1,084	$187,702
2024	292	2,992	$388,980

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	270	$12,285
2016	79	309	$9,863
2017	64	264	$6,779
2018	69	277	$6,601
2019	26	160	$2,041
2020	N/R	67	$1,164
2021	N/R	12	$875
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	19	$308

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	16	16	$131
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	14	14	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	36	76	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	64	75	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	43	1,634	$48,177
Trulicity	Dulaglutide	29	1,317	$43,754
Mounjaro	Tirzepatide	16	896	$32,091
Jardiance	Empagliflozin	19	1,720	$31,654
Farxiga	Dapagliflozin Propanediol	19	1,650	$29,519

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	19	$308

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$845	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Michael Bohrer, D.O.?

Tedicare shows public-source Medicare data for Aaron Michael Bohrer, D.O. (NPI 1548472079), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Michael Bohrer, D.O. have ACO affiliation data?

Aaron Michael Bohrer, D.O. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Aaron Michael Bohrer, D.O.?

Aaron Michael Bohrer, D.O. is linked to MCLAREN GREATER LANSING (billing NPI 1265579734) in the available physician profile data.

Does Aaron Michael Bohrer, D.O. have Open Payments data?

Aaron Michael Bohrer, D.O. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.